{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:53:18Z","timestamp":1791028398983,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001146","name":"Greenwall Foundation","doi-asserted-by":"publisher","award":["Making A Difference Grant"],"award-info":[{"award-number":["Making A Difference Grant"]}],"id":[{"id":"10.13039\/100001146","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Health Care and Philos"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11019-026-10358-y","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:41:06Z","timestamp":1780731666000},"page":"737-745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should we be testing pregnant patients\u2019 urine for drugs? An applied ethics approach"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-2649","authenticated-orcid":false,"given":"Erica","family":"Holland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ieong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"10358_CR36","doi-asserted-by":"crossref","unstructured":"Alexandra Rubin, Lydia Zhong, Lauren Nacke et al. 2022. Urine Drug Screening for Isolated Marijuana Use in Labor and Delivery Units. Obstetrics and Gynecology 140(4):607-609. PMID: 36083598.","DOI":"10.1097\/AOG.0000000000004930"},{"key":"10358_CR1","unstructured":"AMA Principles of Medical Ethics. n.d. Accessed March 28. 2025. https:\/\/code-medical-ethics.ama-assn.org\/principles"},{"key":"10358_CR2","doi-asserted-by":"publisher","unstructured":"Austin, Anna E., B. Rebecca, and Naumann, Elizabeth Simmons. 2022. Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy. JAMA Pediatrics 176(11). https:\/\/doi.org\/10.1001\/JAMAPEDIATRICS.2022.3396","DOI":"10.1001\/JAMAPEDIATRICS.2022.3396"},{"key":"10358_CR3","unstructured":"Beauchamp, Tom L., and James F. Childress. 2012. Principles of Biomedical Ethics. 7th ed. Oxford University Press."},{"issue":"17","key":"10358_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJM199004263221706","volume":"322","author":"I Chasnoff","year":"1990","unstructured":"Chasnoff, I., H. J. Landress, and M. E. Barrett. 1990. The Prevalence of Illicit-Drug or Alcohol Use during Pregnancy and Discrepancies in Mandatory Reporting in Pinellas County, Florida. The New England Journal of Medicine 322(17):1202\u20131206. https:\/\/doi.org\/10.1056\/NEJM199004263221706","journal-title":"The New England Journal of Medicine"},{"key":"10358_CR5","doi-asserted-by":"publisher","unstructured":"Chin, Jennifer M., Eileen Chen, and Tricia Wright et al. 2022. Urine Drug Screening on Labor and Delivery. American Journal of Obstetrics and Gynecology MFM 4(6). https:\/\/doi.org\/10.1016\/J.AJOGMF.2022.100733","DOI":"10.1016\/J.AJOGMF.2022.100733"},{"key":"10358_CR6","doi-asserted-by":"publisher","unstructured":"Ecker, Jeffrey, Alfred Abuhamad, and Washington Hill et al. 2019. Substance Use Disorders in Pregnancy: Clinical, Ethical, and Research Imperatives of the Opioid Epidemic: A Report of a Joint Workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society Of. American Journal of Obstetrics and Gynecology 1\u201324. https:\/\/doi.org\/10.1016\/j.ajog.2019.03.022","DOI":"10.1016\/j.ajog.2019.03.022"},{"issue":"14","key":"10358_CR29","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/14767058.2016.1222369","volume":"30","author":"Tucker Edmonds","year":"2017","unstructured":"Edmonds, Tucker, F. Brownsyne, Mckenzie, M. B. Austgen, A. E. Carroll, and E. M. Meslin. 2017. Women\u2019s Opinions of Legal Requirements for Drug Testing in Prenatal Care. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 30(14):1693\u20131698. https:\/\/doi.org\/10.1080\/14767058.2016.1222369","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians"},{"key":"10358_CR15","doi-asserted-by":"publisher","unstructured":"Ellsworth, M. A., T. P. Stevens, and C. T. D\u2019Angio. 2010. Infant Race Affects Application of Clinical Guidelines When Screening for Drugs of Abuse in Newborns. Pediatrics 125(6). https:\/\/doi.org\/10.1542\/PEDS.2008-3525","DOI":"10.1542\/PEDS.2008-3525"},{"key":"10358_CR7","doi-asserted-by":"publisher","unstructured":"Faherty, Laura J., M. Ashley, Joshua Kranz, Stephen W. Russell-Fritch, Jonathan Patrick, and Cantor, Bradley D. Stein. 2019. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome. JAMA Network Open 2(11). https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2019.14078","DOI":"10.1001\/JAMANETWORKOPEN.2019.14078"},{"issue":"6","key":"10358_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10995-025-04107-5","volume":"29","author":"Leah L Habersham","year":"2025","unstructured":"Habersham, Leah L., L. Candice, J. Woolfolk, Kima, Mishka Taylor, and Terplan, Katrina Mark. 2025. Factors Associated with Positive Toxicology at Delivery: Insights From the University of Maryland Medical System. Maternal and Child Health Journal 29(6):783\u2013790. https:\/\/doi.org\/10.1007\/s10995-025-04107-5","journal-title":"Maternal and Child Health Journal"},{"issue":"8","key":"10358_CR9","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"Marilyn A Huestis","year":"2007","unstructured":"Huestis, Marilyn A. 2007. Human Cannabinoid Pharmacokinetics. Chemistry & Biodiversity 4(8):1770\u20131804. https:\/\/doi.org\/10.1002\/cbdv.200790152","journal-title":"Chemistry & Biodiversity"},{"issue":"4","key":"10358_CR10","doi-asserted-by":"publisher","first-page":"e230441","DOI":"10.1001\/jamahealthforum.2023.0441","volume":"4","author":"Marian Jarlenski","year":"2023","unstructured":"Jarlenski, Marian, Jay Shroff, Mishka Terplan, Sarah C. M. Roberts, Brittany Brown-Podgorski, and Elizabeth E. Krans. 2023. Association of Race With Urine Toxicology Testing Among Pregnant Patients During Labor and Delivery. JAMA Health Forum 4(4):e230441. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.0441","journal-title":"JAMA Health Forum"},{"issue":"2","key":"10358_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.chiabu.2003.07.004","volume":"28","author":"Bonnie D Kerker","year":"2004","unstructured":"Kerker, Bonnie D., M. Sarah, and Horwitz, John M. Leventhal. 2004. Patients\u2019 Characteristics and Providers\u2019 Attitudes: Predictors of Screening Pregnant Women for Illicit Substance Use. Child Abuse and Neglect 28(2):209\u2013223. https:\/\/doi.org\/10.1016\/j.chiabu.2003.07.004","journal-title":"Child Abuse and Neglect"},{"key":"10358_CR12","doi-asserted-by":"publisher","unstructured":"Koenigs, Kathleen J., H. Joseph, Samuel Chou, and Cohen et al. 2022. Informed Consent Is Poorly Documented When Obtaining Toxicology Testing at Delivery in a Massachusetts Cohort. American Journal of Obstetrics & Gynecology MFM 4(4). https:\/\/doi.org\/10.1016\/J.AJOGMF.2022.100621","DOI":"10.1016\/J.AJOGMF.2022.100621"},{"issue":"2","key":"10358_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/phe\/phac002","volume":"15","author":"Katja Kuehlmeyer","year":"2022","unstructured":"Kuehlmeyer, Katja, Marcel Mertz, Joschka Haltaufderheide, Alexander Kremling, Sebastian Schleidgen, and Julia Inthorn. 2022. Empirical Research and Recommendations for Moral Action: A Plea for the Transparent Reporting of Bridge Principles in Public Health Research. Public Health Ethics 15(2):147\u2013159.","journal-title":"Public Health Ethics"},{"key":"10358_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004808","author":"Theresa Kurtz","year":"2022","unstructured":"Kurtz, Theresa, Marcela C. Smid. 2022. Challenges in Perinatal Drug Testing. Obstetrics & Gynecology. ahead of print, July 7. https:\/\/doi.org\/10.1097\/AOG.0000000000004808","journal-title":"Obstetrics & Gynecology"},{"key":"10358_CR35","doi-asserted-by":"crossref","unstructured":"Leela Sarathy, Joseph H Chou, Paul H Lerou et al. 2023. Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use. Hospital pediatrics 13(4):317-325. PMID: 36855896","DOI":"10.1542\/hpeds.2022-006897"},{"issue":"2","key":"10358_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/00221465211058152","volume":"63","author":"Katharine McCabe","year":"2022","unstructured":"McCabe, Katharine. 2022. Criminalization of Care: Drug Testing Pregnant Patients. Journal of Health and Social Behavior 63(2):162\u2013176. https:\/\/doi.org\/10.1177\/00221465211058152","journal-title":"Journal of Health and Social Behavior"},{"issue":"3","key":"10358_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/AOG.0000000000003986","volume":"136","author":"NC Perlman","year":"2020","unstructured":"Perlman, N. C., D. E. Cantonwine, and N. A. Smith. 2020. Toxicology Testing in Pregnancy: Evaluating the Role of Social Profiling. Obstetrics and Gynecology 136(3):607\u2013609. https:\/\/doi.org\/10.1097\/AOG.0000000000003986","journal-title":"Obstetrics and Gynecology"},{"key":"10358_CR18","doi-asserted-by":"publisher","unstructured":"Perlman, Nicola C., David E. Cantonwine, and Nicole A. Smith. 2022. Racial Differences in Indications for Obstetrical Toxicology Testing and Relationship of Indications to Test Results. American Journal of Obstetrics & Gynecology MFM 4(1). https:\/\/doi.org\/10.1016\/J.AJOGMF.2021.100453","DOI":"10.1016\/J.AJOGMF.2021.100453"},{"issue":"2","key":"10358_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.siny.2019.01.007","volume":"24","author":"Kathryn Polak","year":"2019","unstructured":"Polak, Kathryn, and Sydney Kelpin, Mishka Terplan. 2019. Screening for Substance Use in Pregnancy and the Newborn. Seminars in Fetal and Neonatal Medicine 24(2):90\u201394. https:\/\/doi.org\/10.1016\/j.siny.2019.01.007","journal-title":"Seminars in Fetal and Neonatal Medicine"},{"issue":"1","key":"10358_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11414-011-9247-x","volume":"39","author":"Sarah CM Roberts","year":"2012","unstructured":"Roberts, Sarah C. M., and Amani Nuru-Jeter. 2012. Universal Screening for Alcohol and Drug Use and Racial Disparities in Child Protective Services Reporting. Journal of Behavioral Health Services and Research 39(1):3\u201316. https:\/\/doi.org\/10.1007\/s11414-011-9247-x","journal-title":"Journal of Behavioral Health Services and Research"},{"key":"10358_CR21","doi-asserted-by":"publisher","unstructured":"Russ, Hans, Johannes Clouth, and Franz Porzsolt. 2006. Theory Behind the Bridge Principles. In Optimizing Health: Improving the Value of Healthcare Delivery, edited by Franz Porzsolt and Robert M. Kaplan. Springer US. https:\/\/doi.org\/10.1007\/978-0-387-33921-4_6","DOI":"10.1007\/978-0-387-33921-4_6"},{"key":"10358_CR22","doi-asserted-by":"publisher","unstructured":"Schleidgen, Sebastian, Alexander Kremling, Marcel Mertz, Katja Kuehlmeyer, and Julia Inthorn, Joschka Haltaufderheide. 2022. How to Derive Ethically Appropriate Recommendations for Action? A Methodology for Applied Ethics. Medicine Health Care and Philosophy 1. https:\/\/doi.org\/10.1007\/S11019-022-10133-9","DOI":"10.1007\/S11019-022-10133-9"},{"key":"10358_CR23","doi-asserted-by":"crossref","unstructured":"Schwartz, L., E. Yeo, and M. Siegel. 2023. Consent for Toxicology Testing during Pregnancy: A Qualitative Study of Patient and Clinician Perspectives. Paper presented at Society for Maternal-Fetal Medicine Annual Meeting.","DOI":"10.1016\/j.ajog.2022.11.329"},{"key":"10358_CR34","doi-asserted-by":"crossref","unstructured":"Scott L Wexelblatt, Laura P Ward, Kimberly Torok et al. 2015. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse. Journal of Pediatrics 166(3):582-6. PMID: 25454935","DOI":"10.1016\/j.jpeds.2014.10.004"},{"issue":"6","key":"10358_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ajog.2022.11.1293","volume":"228","author":"Molly R Siegel","year":"2023","unstructured":"Siegel, Molly R., K. Grace, Sacha N. Mahowald, and Uljon et al. 2023. Fentanyl in the Labor Epidural Impacts the Results of Intrapartum and Postpartum Maternal and Neonatal Toxicology Tests. American Journal of Obstetrics and Gynecology 228(6):741. https:\/\/doi.org\/10.1016\/j.ajog.2022.11.1293. .e1-741.e7.","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"September","key":"10358_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejogrb.2018.07.020","volume":"228","author":"Shannon L Son","year":"2018","unstructured":"Son, Shannon L., Maryam Guiahi, and Kent D. Heyborne. 2018. Historical and Clinical Factors Associated with Positive Urine Toxicology Screening on Labor and Delivery. European Journal of Obstetrics Gynecology and Reproductive Biology 228(September):261\u2013266. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.07.020","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"key":"10358_CR26","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. HHS Publication No. (SMA) 18-5054. Rockville, MD: Substance Abuse and Mental Health Services Administration. 2018."},{"key":"10358_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004884","author":"Mishka Terplan","year":"2022","unstructured":"Terplan, Mishka. 2022. Test or Talk: Empiric Bias and Epistemic Injustice. Obstetrics & Gynecology. ahead of print, July 7. https:\/\/doi.org\/10.1097\/AOG.0000000000004884","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10358_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/AOG.0000000000001781","volume":"129","author":"Mishka Terplan","year":"2017","unstructured":"Terplan, Mishka, Howard Minkoff. 2017. Neonatal Abstinence Syndrome and Ethical Approaches to the Identification of Pregnant Women Who Use Drugs. Obstetrics & Gynecology 129(1):164\u2013167. https:\/\/doi.org\/10.1097\/AOG.0000000000001781","journal-title":"Obstetrics & Gynecology"},{"issue":"November","key":"10358_CR30","doi-asserted-by":"publisher","first-page":"110985","DOI":"10.1016\/j.drugalcdep.2023.110985","volume":"252","author":"Karla D Wagner","year":"2023","unstructured":"Wagner, Karla D., Phillip Fiuty, and Kimberly Page et al. 2023. Prevalence of Fentanyl in Methamphetamine and Cocaine Samples Collected by Community-Based Drug Checking Services. Drug and Alcohol Dependence 252(November):110985. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.110985","journal-title":"Drug and Alcohol Dependence"},{"key":"10358_CR31","doi-asserted-by":"publisher","unstructured":"Wanar, Amita, Breanna Cassidy Isley, Kelley Saia, and Thomas A. Field. 2022. False-Positive Fentanyl Urine Detection after Initiation of Labetalol Treatment for Hypertension in Pregnancy: A Case Report. Journal of Addiction Medicine 16(6). https:\/\/doi.org\/10.1097\/ADM.0000000000001010","DOI":"10.1097\/ADM.0000000000001010"},{"key":"10358_CR32","unstructured":"WMA - The World Medical Association-WMA International Code of Medical Ethics. n.d. Accessed March 28, 2025. https:\/\/www.wma.net\/policies-post\/wma-international-code-of-medical-ethics\/"},{"issue":"2 Pt 2","key":"10358_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/AOG.0b013e318206c07c","volume":"117","author":"Lynn M Yee","year":"2011","unstructured":"Yee, Lynn M., Danny Wu. 2011. False-Positive Amphetamine Toxicology Screen Results in Three Pregnant Women Using Labetalol. Obstetrics and Gynecology 117(2 Pt 2):503\u2013506. https:\/\/doi.org\/10.1097\/AOG.0b013e318206c07c","journal-title":"Obstetrics and Gynecology"}],"container-title":["Medicine, Health Care and Philosophy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-026-10358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11019-026-10358-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-026-10358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:08:18Z","timestamp":1791025698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11019-026-10358-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10358"],"URL":"https:\/\/doi.org\/10.1007\/s11019-026-10358-y","relation":{},"ISSN":["1386-7423","1572-8633"],"issn-type":[{"value":"1386-7423","type":"print"},{"value":"1572-8633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Holland is an obstetrician in a clinical practice serving patients with substance use disorder. She was part of a team that revised Boston Medical Center\u2019s policy on urine drug testing in pregnancy and received funding through the Greenwall Foundation to study the impact of this policy revision. The authors have no other financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Statements and declarations","group":{"name":"EthicsHeading","label":"Declarations"}}]}}